CONTRAINDICATIONS:
Do not take BINAV if you are allergic to BINAV or to any of its ingredients. The active ingredients in BINAV are emtricitabine and tenofovir DF.
Do not take BINAV (emtricitabine + tenofovir disoproxil fumarate) if you are also taking any of the medicines listed below:
• Emtricitabine or tenofovir. These medicines contain the same active ingredient as BINAV (emtricitabine + tenofovir disoproxil fumarate).
• Medicines containing lamivudine or tenofovir alafenamide or adefovir (HEPSERA®).
For people taking BINAV (emtricitabine + tenofovir disoproxil fumarate) for pre-exposure prophylaxis to reduce the risk of HIV-1 infection:
BINAV (emtricitabine + tenofovir disoproxil fumarate) can only help reduce your risk of becoming infected with HIV-1 before you become infected. Do not take BINAV (emtricitabine + tenofovir disoproxil fumarate) for pre-exposure prophylaxis to help reduce your risk of becoming infected with HIV-1 if:
• You already have HIV-1 infection. If you are HIV positive, you must take other medicines used to treat HIV-1 together with BINAV (emtricitabine + tenofovir disoproxil fumarate). BINAV (emtricitabine + tenofovir disoproxil fumarate) alone is not a complete treatment for HIV-1.
• You do not know your HIV-1 infection status. You may already be HIV-positive. You need to take other HIV-1 medications with BINAV (emtricitabine + tenofovir disoproxil fumarate) to treat HIV-1.
Category B: This medicine should not be used by pregnant women without guidance from a doctor or surgeon-dentist.